USD 0.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 598.64 Thousand USD | -12.23% |
2004 | 682.05 Thousand USD | 0.0% |
2003 | 682.05 Thousand USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | -100.0% |
2000 | 2.5 Million USD | -51.46% |
1999 | 5.15 Million USD | -13.45% |
1998 | 5.95 Million USD | 0.0% |
1997 | - USD | -100.0% |
1996 | 400 Thousand USD | -33.33% |
1995 | 600 Thousand USD | -25.0% |
1994 | 800 Thousand USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | -100.0% |
1990 | 1.7 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 Q2 | 579.7 Thousand USD | -1.29% |
2006 Q3 | 568.33 Thousand USD | -1.96% |
2006 FY | - USD | -100.0% |
2006 Q4 | - USD | -100.0% |
2006 Q1 | 587.27 Thousand USD | -1.9% |
2005 Q2 | 621.37 Thousand USD | -1.8% |
2005 Q1 | 632.74 Thousand USD | -7.23% |
2005 FY | 598.64 Thousand USD | -12.23% |
2005 Q4 | 598.64 Thousand USD | -1.86% |
2005 Q3 | 610.01 Thousand USD | -1.83% |
2004 Q4 | 682.05 Thousand USD | 0.0% |
2004 Q2 | 682.05 Thousand USD | 0.0% |
2004 Q3 | 682.05 Thousand USD | 0.0% |
2004 Q1 | 682.05 Thousand USD | 0.0% |
2004 FY | 682.05 Thousand USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | 682.05 Thousand USD | 0.0% |
2003 FY | 682.05 Thousand USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 Q2 | 1.5 Million USD | -25.0% |
2001 Q1 | 2 Million USD | -20.0% |
2001 Q3 | - USD | -100.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | -100.0% |
2000 Q4 | 2.5 Million USD | -20.63% |
2000 Q1 | 4.15 Million USD | -19.32% |
2000 FY | 2.5 Million USD | -51.46% |
2000 Q2 | 4.15 Million USD | 0.0% |
2000 Q3 | 3.15 Million USD | -24.19% |
1999 Q1 | 5.45 Million USD | -8.4% |
1999 Q4 | 5.15 Million USD | 0.0% |
1999 Q3 | 5.15 Million USD | 0.0% |
1999 Q2 | 5.15 Million USD | -5.5% |
1999 FY | 5.15 Million USD | -13.45% |
1998 Q1 | - USD | 0.0% |
1998 FY | 5.95 Million USD | 0.0% |
1998 Q4 | 5.95 Million USD | 10.19% |
1998 Q3 | 5.4 Million USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 FY | - USD | -100.0% |
1997 Q4 | - USD | 0.0% |
1997 Q2 | - USD | -100.0% |
1997 Q1 | 400 Thousand USD | 0.0% |
1996 Q3 | 400 Thousand USD | 0.0% |
1996 Q4 | 400 Thousand USD | 0.0% |
1996 FY | 400 Thousand USD | -33.33% |
1996 Q2 | 400 Thousand USD | -33.33% |
1996 Q1 | 600 Thousand USD | 0.0% |
1995 FY | 600 Thousand USD | -25.0% |
1995 Q4 | 600 Thousand USD | 0.0% |
1995 Q1 | 800 Thousand USD | 0.0% |
1995 Q2 | 600 Thousand USD | -25.0% |
1995 Q3 | 600 Thousand USD | 0.0% |
1994 Q4 | 800 Thousand USD | -20.0% |
1994 Q2 | 800 Thousand USD | 166.67% |
1994 Q1 | 300 Thousand USD | 0.0% |
1994 Q3 | 1 Million USD | 25.0% |
1994 FY | 800 Thousand USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1991 FY | - USD | -100.0% |
1991 Q1 | 2.1 Million USD | 23.53% |
1991 Q2 | 100 Thousand USD | -95.24% |
1991 Q4 | - USD | 0.0% |
1991 Q3 | - USD | -100.0% |
1990 Q4 | 1.7 Million USD | 0.0% |
1990 FY | 1.7 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Ansell Limited | 705.27 Million USD | 100.0% |
Ansell Limited | 706.6 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 22.41 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | - USD | NaN% |
Psykey, Inc. | 625 Thousand USD | 100.0% |
ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
Encision Inc. | 67.33 Thousand USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 382.83 Thousand USD | 100.0% |
LifePoint, Inc. | 151.73 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | - USD | NaN% |
Reflect Scientific, Inc. | 179.96 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 849.37 Million USD | 100.0% |
Sector 10, Inc. | - USD | NaN% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 100.0% |
SheerVision, Inc. | - USD | NaN% |
United Health Products, Inc. | 48.48 Thousand USD | 100.0% |
Vasamed, Inc. | 18.95 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | 100.0% |
Yubo International Biotech Limited | 390.44 Thousand USD | 100.0% |